Tumor Treating Fields—a review and graphic

Treatment for glioblastoma approved in 2015.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406491/

https://www.ncbi.nlm.nih.gov/pubmed/29349613https://www.ncbi.nlm.nih.gov/pubmed/29349613

https://www.ncbi.nlm.nih.gov/pubmed/28298023

“In 2011, the United States Food and Drug Administration (FDA) approved a tumor treating fields (TTF) device for treatment of recurrent or refractory GBM. More recently, the FDA approved the TTF device as adjuvant treatment for newly-diagnosed patients after completing standard-of-care surgery and chemoradiation. The National Comprehensive Cancer Network (NCCN) added the TTF device as an option for treatment of newly-diagnosed GBM. Despite FDA approval, skepticism remains regarding this therapy. In this review we discuss the current evidence supporting treatment with the TTF device and its limitations.”

TT Fields Treatment https://www.hopkinsmedicine.org/health/conditions-and-diseases/brain-tumor/tt-fields-tumortreating-fields-for-brain-tumors

• The TT fields treatment device is portable and may help people treat their cancer while continuing their normal activities.
  
• People undergoing TT fields therapy use small transducers that are attached to their head with adhesive bandages. Hair must be shaved in order to use the device.
  
• The transducers are connected to wires, which are plugged into a battery that is about the size of a book. The batteries fit into a bag that the person carries with them, either in a backpack, across the body, or over the shoulder like a messenger bag.
  
• The system comes with multiple batteries and a charging station. The user is alerted when batteries need to be changed.
  
• The therapy is continual, but people can unplug the device for short times